🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Romanos Sklavenitis‐Pistofidis

Broad Institute

ORCID: 0000-0002-8025-9850

Also affiliated with Boston University, Boston Medical Center, Harvard University, Aristotle University of Thessaloniki, Dana-Farber Cancer Institute, Massachusetts Institute of Technology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.595Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic landscape of multiple myeloma and its precursor conditions

Nature Genetics(2025)10.1038/s41588-025-02196-0
Top 33%
0.595DataRank
Top 33%29 citations

Ankit K. Dutta, Andrea Poletti, Tim H. H. Coorens, Elizabeth D. Lightbody, Rosa Toenges +33 more

Papers

Driven by 13 papers — median percentile 67. Top paper: “Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma”.

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Cancer Cell(2022)10.1016/j.ccell.2022.10.017
N/A
0.626DataRank · unranked
64 citations

Michelle P. Aranha, Robert Redd, Joanna Bagińska, Nicholas J. Haradhvala, Margaret Hallisey +34 more

Genomic landscape of multiple myeloma and its precursor conditions

Nature Genetics(2025)10.1038/s41588-025-02196-0
Top 33%
0.595DataRank
Top 33%29 citations

Ankit K. Dutta, Andrea Poletti, Tim H. H. Coorens, Elizabeth D. Lightbody, Rosa Toenges +33 more

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0210
N/A
0.516DataRank · unranked
16 citations

Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis‐Pistofidis, Bachisio Ziccheddu +14 more

Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma

Cancer Research(2024)10.1158/0008-5472.can-24-1440
N/A
0.386DataRank · unranked
7 citations

Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco +9 more

Diagnostic TR-FRET assays for detection of antibodies in patient samples

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100421
N/A
0DataRank · unranked
6 citations

Radosław P. Nowak, Daan Overwijn, N. Connor Payne, Stephanie Fischinger, Caroline Atyeo +18 more

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.01.551480
N/A
0DataRank · unranked
2 citations

Elizabeth D. Lightbody, Mairéad Reidy, Junko Tsuji, Michelle P. Aranha, Daniel Heilpern-Mallory +15 more

Genomic Profiling to Contextualize the Results of Intervention for High-Risk Smoldering Myeloma

medRxiv(2023)10.1101/2023.08.30.23294483
N/A
0DataRank · unranked
1 citations

Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis‐Pistofidis, Bachisio Ziccheddu +14 more

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

Nature Communications(2025)10.1038/s41467-024-55308-5
N/A
0DataRank · unranked
14 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Journal of Clinical Oncology(2020)10.1200/jco.20.00437
N/A
0DataRank · unranked
182 citations

Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Benny Zhitomirsky, Andrew Dunford +31 more

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia

Nature Communications(2025)10.1038/s41467-025-56323-w
N/A
0DataRank · unranked
13 citations

Yoshinobu Konishi, Daniel Heilpern-Mallory, Ting Wu, Nicholas Tsakmaklis, Michelle P. Aranha +17 more

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.10.471975
N/A
0DataRank · unranked
0 citations

Shankara Anand, Romanos Sklavenitis‐Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky +22 more

MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0482
N/A
0DataRank · unranked
38 citations

Jean-Baptiste Alberge, Elizabeth D. Lightbody, Cody J. Boehner, Andrew Dunford, Romanos Sklavenitis‐Pistofidis +19 more

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Nature Communications(2022)10.1038/s41467-022-30694-w
N/A
0DataRank · unranked
33 citations

Shankara Anand, Romanos Sklavenitis‐Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky +22 more